LifeVantage (NASDAQ:LFVN) Shares Cross Above 200-Day Moving Average of $6.32

LifeVantage Co. (NASDAQ:LFVNGet Free Report)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $6.32 and traded as high as $7.54. LifeVantage shares last traded at $7.36, with a volume of 42,411 shares traded.

LifeVantage Price Performance

The stock has a market cap of $95.63 million, a PE ratio of 26.89 and a beta of 0.80. The business has a 50 day simple moving average of $6.53 and a 200 day simple moving average of $6.32.

LifeVantage (NASDAQ:LFVNGet Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $0.21 earnings per share (EPS) for the quarter. LifeVantage had a net margin of 1.75% and a return on equity of 27.02%. The firm had revenue of $48.25 million during the quarter.

LifeVantage Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Friday, May 31st will be given a dividend of $0.04 per share. The ex-dividend date of this dividend is Friday, May 31st. This is a boost from LifeVantage’s previous quarterly dividend of $0.04. This represents a $0.16 dividend on an annualized basis and a dividend yield of 2.12%. LifeVantage’s payout ratio is currently 50.00%.

Institutional Trading of LifeVantage

Hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of LifeVantage by 2.8% during the first quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock worth $2,874,000 after purchasing an additional 12,809 shares during the period. Acadian Asset Management LLC raised its stake in LifeVantage by 2.8% in the first quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after buying an additional 6,121 shares during the period. Empowered Funds LLC boosted its position in LifeVantage by 8.1% during the first quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock worth $461,000 after purchasing an additional 5,742 shares during the period. O Shaughnessy Asset Management LLC increased its holdings in shares of LifeVantage by 135.4% in the third quarter. O Shaughnessy Asset Management LLC now owns 48,506 shares of the company’s stock valued at $313,000 after purchasing an additional 27,897 shares during the last quarter. Finally, Ritholtz Wealth Management raised its position in shares of LifeVantage by 23.5% in the fourth quarter. Ritholtz Wealth Management now owns 25,027 shares of the company’s stock valued at $150,000 after purchasing an additional 4,756 shares during the period. 35.32% of the stock is currently owned by institutional investors and hedge funds.

LifeVantage Company Profile

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Featured Articles

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.